Advancing Outcomes Through Strategic Partnerships
Next Science expands the potential applications of its novel Xbio™ technology through industry partnerships.
Next Science has entered into an exclusive, worldwide distribution agreement with US-based diversified manufacturer 3M Company for the sales and marketing of Next Science’s BlastX™ Antimicrobial Wound Gel. BlastX Antimicrobial Wound Gel is powered by Next Science’s patented Xbio™ Technology that provides an optimal environment for wound healing, which has been shown to help improve outcomes for patients suffering from chronic wounds.
3M applies science in collaborative ways to improve lives daily. With $32 billion in sales, their 91,000 employees connect with customers all around the world. Learn more about 3M’s creative solutions to the world’s problems at www.3M.com or on Twitter @3M or @3MNews.
Next Science and Zimmer Biomet have partnered with an exclusive global distribution agreement for Bactisure™ Wound Lavage in the surgical space. Bactisure is a sterile, aqueous solution used to remove debris – including microorganisms – from wounds using pulsed (jet) lavage. Used as an adjunct to normal saline lavage, Bactisure is a 510(K) cleared device and is available from Zimmer Biomet globally.
Zimmer Biomet was founded in 1927 and is a global leader in musculoskeletal healthcare. Zimmer Biomet designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants and related surgical products.
MPN-WEB-018 Rev B